title: Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trial.
authors.affiliation: AP-HP, Laboratoire de Virologie, CHU Necker-Enfants Malades, Paris, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Avettand-Fenoel
authors.forename: Philippe
authors.initials: P
authors.lastname: Flandre
authors.forename: Marie-Laure
authors.initials: ML
authors.lastname: Chaix
authors.forename: Jade
authors.initials: J
authors.lastname: Ghosn
authors.forename: Constance
authors.initials: C
authors.lastname: Delaugerre
authors.forename: François
authors.initials: F
authors.lastname: Raffi
authors.forename: Philippe
authors.initials: P
authors.lastname: Ngovan
authors.forename: Isabelle
authors.initials: I
authors.lastname: Cohen-Codar
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Delfraissy
authors.forename: Christine
authors.initials: C
authors.lastname: Rouzioux
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001773:Blood Cells / Q000821:virology*; D004279:DNA, Viral / Q000032:analysis* / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D061466:Lopinavir; D016133:Polymerase Chain Reaction / Q000379:methods; D011744:Pyrimidinones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir